Largely in response to interest in the biobased chemicals sector by Wall Street, Genomatica hopes to capitalize on this by planning to raise up to $150 million, possibly through a stock offering. The Chief Executive Christophe Schilling stated this at the Reuters Global Energy and Climate Summit on 13th June. “We’re actively looking at the situation in both public and private markets. For us to get to a point where we would see profitability, we’re talking about raising anywhere on the order of $100 million to $150 million. A lot of sovereign wealth funds are highly interested in this area… Login to continue

Login or sign up